Randomized control study of the use of faropenem for treating patients with pulmonary tuberculosis

ABSTRACT: Objectives: Faropenem has antituberculosis activity in vitro but its utility in treating patients with tuberculosis (TB) is unclear. Methods: We conducted an open-label, randomized trial in China, involving newly diagnosed, drug-susceptible pulmonary TB. The control group was treated with...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yanwan Shangguan, Wanru Guo, Xuewen Feng, Yunzhen Shi, Xiaomeng Li, Zhifen Pan, Ming Hu, Jichan Shi, Cheng Ding, Jiafeng Xia, Wenjuan Hu, Zhongkang Ji, Chengjie Zhao, Yuecui Li, Zebao He, Lingxiao Jin, Xiaodong Tao, Xinming Zhu, Xiaoqiang Zhang, Qun Song, Yuyin Zhu, Lin Zheng, Xiuyuan Jin, Shujuan Huang, Liangxiu Jiang, Yuping Wang, Tiantian Wu, Dan Cao, Ying Zhang, Lanjuan Li, Kaijin Xu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-07-01
Edice:	International Journal of Infectious Diseases
Témata:	Tuberculosis Treatment Faropenem
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S1201971223005180
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!